In technical analysis, a Death Crossover is considered a bearish indicator signaling possible price declines. This pattern forms when a short-term moving average, commonly the 50-day, crosses below a long-term moving average, such as the 200-day. It reflects weakening recent momentum relative to the broader trend, suggesting potential downside movement in the stock’s price.
For traders and investors, the Death Crossover acts as a cautionary signal, often hinting at the start of a potential downtrend in a stock’s price. While it doesn’t ensure a decline, it indicates rising selling pressure and waning buying interest. Many market participants use this signal in combination with other technical indicators to assess market sentiment and make more informed investment decisions.
Here are a few 3 Nifty 500 stocks with a Death Crossover
Bayer Cropscience India Limited
Bayer CropScience India Limited was established in 1958 and is a leading company in agricultural solutions. It manufactures and sells insecticides, fungicides, herbicides, and plant protection products to support farmers’ crop health and yield in India.
The death crossover took place on the 15th of October 2025, at the price of Rs. 5,280.22 with a decent volume of 12.73 K. The stock closed at Rs. 5,023.40 in Friday’s session, reflecting a 1.76 percent decrease in the intraday trade.
Emami Limited
Emami Limited was founded in 1974 by R.S. Agarwal and R.S. Goenka in Kolkata. The company manufactures and markets personal care and healthcare products. Its popular brands include BoroPlus, Navratna, and Fair & Handsome, serving millions across India and worldwide.
The death crossover took place on the 15th of October 2025, at the price of Rs. 580.55 with a decent volume of 672.41 K. The stock closed at Rs 551.50 in Friday’s session, reflecting a 2.33 percent increase in the intraday trade.
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited (GSK India) was established in 1924 as H.J. Foster & Co. Limited, later renamed Glaxo Laboratories (I) Ltd in 1950. It is a research-based pharmaceutical company offering prescription medicines and vaccines across therapeutic areas like anti-infectives, dermatology, diabetes, oncology, and respiratory diseases.
The death crossover took place on the 15th of October 2025, at the price of Rs. 2,758.01 with a decent volume of 33.15 K. The stock closed at Rs. 2,742.90 in Friday’s session, reflecting a 0.70 percent increase in the intraday trade.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
